scispace - formally typeset
C

Colin Ray

Researcher at University of Copenhagen

Publications -  35
Citations -  1064

Colin Ray is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Lactose & Whey protein. The author has an hindex of 14, co-authored 34 publications receiving 751 citations. Previous affiliations of Colin Ray include Royal Institute of Technology & Arla Foods.

Papers
More filters
Journal ArticleDOI

Control of Maillard Reactions in Foods: Strategies and Chemical Mechanisms

TL;DR: Recent advances in strategies for controlling the Maillard reaction and subsequent downstream reaction products in food systems are critically reviewed.
Journal ArticleDOI

Lactose-Hydrolyzed Milk Is More Prone to Chemical Changes during Storage than Conventional Ultra-High-Temperature (UHT) Milk

TL;DR: Observations indicate more favorable conditions for Maillard and subsequent reactions in lactose-hydrolyzed milk compared to conventional UHT milk stored at ambient temperature and it is postulated that proteolytic activity from the lactase-enzyme preparation may be responsible for the observed higher levels of free amino acids.
Journal ArticleDOI

Sulfonimidamides as sulfonamides bioisosteres: rational evaluation through synthetic, in vitro, and in vivo studies with γ-secretase inhibitors.

TL;DR: Detailed in vitro and in vivo profiling reveal that the sulfonimidamide motif imparts desirable properties such as decreased lipophilicity and plasma protein binding, accompanied by increased solubility, which support a wider use of this unique functional group in the design of new pharmacologically active agents.
Journal ArticleDOI

Substituted 7-amino-5-thio-thiazolo[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1)

TL;DR: The structure-activity relationships showed that a leucinol moiety attached to the core-structure in the 7-position together with α-methyl branched benzyl derivatives in the 5-position displayed promising affinity, and selectivity as well as physicochemical properties, as exemplified by compounds 18a and 24h.
Patent

Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders

TL;DR: In this article, the present invention relates to new compounds of formula (I) Wherein X is or Y; as a free base or a pharmaceutically acceptable salt, solvate or solvates of salt thereof, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.